Sign In
Last checked at 
16 Mar 2016 07:00
16 March 2016
Revolymer plc
("Revolymer" or "the Company")
Appointment of Chief Commercial Officer
Revolymer is delighted to announce that it will appoint Dr Louise Crascall as Chief Commercial Officer with effect from 1 June 2016. Dr Crascall has 20 years of experience in technical and commercial roles in the specialty chemicals industry and will bring significant commercial expertise, along with a broad technical understanding, to augment Revolymer's management team.
Dr Crascall will join Revolymer from Vivimed Labs Europe Ltd, the European operation of Vivimed Labs whose specialty chemicals business makes actives for the personal care industry, where she has served as Commercial Operations Director and Chief Marketing Officer. Prior to that, Dr Crascall had senior commercial and technical sales roles at James Robinson Ltd (acquired by Vivimed Labs) and Uniquema (part of the ICI group, and acquired by Croda). She has a BSc in Chemistry from the University of Bristol and an MSc and PhD in Chemistry from the University of Salford.
"I am excited to have this opportunity to lead Revolymer's commercial team through the continued development of the business, and look forward to working with the existing board and management to build Revolymer into a global leader in its markets" said Dr Crascall.
Kevin Matthews, CEO of Revolymer plc, commented "We are very pleased to have appointed Louise to the role of CCO at Revolymer. She has the balance of relevant commercial and technical experience to build further commercial traction at Revolymer, and we look forward to near-term progress across Revolymer's specialty materials business areas under her leadership."
Ends
For further information please contact:
Revolymer plc | +44 (0) 1244 283 500 |
Kevin Matthews / Rob Cridland
| |
Panmure Gordon (UK) Limited | +44 (0) 20 7886 2500 |
Adam James (Corporate Finance) Charles Leigh-Pemberton (Corporate Broking) |
About Revolymer
Revolymer is an AIM quoted company (registered number 08024489) whose vision is to be a specialty chemicals business focussed on controlled release, responsive systems and delivery systems that improve the functional performance of its customers' products, based on its expertise in the design and synthesis of polymers (often in combination with other materials) to manage the interface between different surfaces and phases.
www.revolymer.com
Follow the stocks
